Tissue & Stem Cell Storage
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
42
NCT02326935
Multi-Center Study Safety of Adipose Derived Mesenchymal Stem Cells for the Treatment of Multiple Sclerosis
Phase: Phase 1
Role: Lead Sponsor
Start: Nov 30, 2014
Completion: May 18, 2018
NCT04744051
ATCell™ Expanded Autologous, Adipose-Derived Mesenchymal Stem Cells Deployed Via Intravenous Infusion
Start: Feb 1, 2021
Completion: Jan 31, 2024
NCT05669261
Treatment of Long COVID Symptoms Utilizing Autologous Stem Cells Following COVID-19 Infection
Start: Aug 1, 2023
Completion: Feb 1, 2024
Loading map...